3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Drug-Related Side Effects and Adverse Reactions
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Breast Neoplasms
1
Interventions
Voriconazole
2
Social Determinants of Health
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
glucarpidase
1
denileukin diftitox
1
bismuth tripotassium dicitrate
1
Ofloxacin
1
Metronidazole
1
Methotrexate
1
Levofloxacin
1
Immunotherapy, Adoptive
1
Esomeprazole
1
Dihydrouracil Dehydrogenase (NADP)
1
Clarithromycin
1
CTLA-4 Antigen
1
Antineoplastic Agents
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Drug-Related Side Effects and Adverse Reactions
×
Social Determinants of Health
×
Clear all
NCT05096338
2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled
NCT05078190
2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled